✦ LIBER ✦

Phase II study of OSI-211 (liposomal lurtotecan) in patients with metastatic or loco-regional recurrent squamous cell carcinoma of the head and neck: An EORTC New Drug Development Group Study

✍ Scribed by F. Duffaud; M. Borner; P. Chollet; J.B. Vermorken; J. Bloch; M. Degardin; F. Rolland; C. Dittrich; B. Baron; D. Lacombe; P. Fumoleau

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase II study of paclitaxel, ifosfamide

✍ Dong M. Shin; Fadlo R. Khuri; Bonnie S. Glisson; Lawrence Ginsberg; Vali M. Papa 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 97 KB 👁 2 views

Evaluation of Gemcitabine in Patients wi

✍ Wolfram E. Samlowski; Holly Gundacker; J. Philip Kuebler; Jeffrey K. Giguere; Gl 📂 Article 📅 2001 🏛 Springer US 🌐 English ⚖ 68 KB

Erlotinib and bevacizumab in patients wi

✍ Ezra EW Cohen; Darren W Davis; Theodore G Karrison; Tanguy Y Seiwert; Stuart J W 📂 Article 📅 2009 🏛 The Lancet 🌐 English ⚖ 442 KB

843 - Phase II study of vinorelbine (NVB

✍ M. Degardin; Ph. Bastit; F. Rolland; J.P. Armand; B. Chevallier; M. Van Glabbeke 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 217 KB

A phase II study of docetaxel in patient

✍ Couteau, C; Chouaki, N; Leyvraz, S; Oulid-Aissa, D; Lebecq, A; Domenge, C; Groul 📂 Article 📅 1999 🏛 Nature Publishing Group 🌐 English ⚖ 63 KB

A phase II study of temsirolimus and erl

✍ Bauman, Julie E.; Arias-Pulido, Hugo; Lee, Sang-Joon; Fekrazad, M. Houman; Ozawa 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 496 KB